| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Mannkind Corporation (MNKD) has 17 insiders with recent SEC Form 4 filings, including 14 buys and 0 sells. MNKD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.03M | $3.99M | - | |
| CEO | 796.0K | $3.10M | - | |
| VP | 460.8K | $1.79M | - | |
| VP | 349.8K | $1.36M | - | |
| Other | 344.2K | $1.34M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2020 | Binder Steven B.68 | Chief Financial Officer | Buy | 1,522 | $1.25 | $1,902.50 | +4.8% | |
| Jul 31, 2020 | Kendall David M | Chief Medical Officer | Buy | 4,041 | $1.25 | $5,051.25 | +10.9% | |
| Jul 31, 2020 | Castagna Michael55 | Chief Executive Officer | Buy | 5,000 | $1.25 | $6,250.00 | +2.5% | |
| Jun 15, 2020 | Castagna Michael55 | Chief Executive Officer | Buy | 40,431 | $1.47 | $59,433.82 | +24.0% | |
| Jan 31, 2020 | Tross Stuart A71 | Chief People &Workpl Officer | Buy | 5,000 | $0.95 | $4,750.00 | +4.2% | |
| Jan 31, 2020 | Castagna Michael55 | Chief Executive Officer | Buy | 5,000 | $0.95 | $4,750.00 | +3.1% | |
| Jan 31, 2020 | Kendall David M | Chief Medical Officer | Buy | 2,304 | $0.95 | $2,188.80 | +4.6% | |
| Jan 31, 2020 | Binder Steven B.68 | Chief Financial Officer | Buy | 2,168 | $0.95 | $2,059.60 | +4.7% | |
| Jan 31, 2020 | McCauley Patrick | Chief Commercial Officer | Buy | 5,000 | $0.95 | $4,750.00 | +5.2% | |
| Jul 31, 2019 | Tross Stuart A71 | Chief People &Workpl Officer | Buy | 5,000 | $0.95 | $4,750.00 | +4.3% |